Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

Coversin

2 clinical trials

2 indications

Indication
Paroxysmal Nocturnal Hemoglobinuria
Indication
Paroxysmal Nocturnal Haemoglobinuria
Clinical trial
CONSENT II: Coversin in Paroxysmal Nocturnal Hemoglobinuria (PNH) in Patients With Resistance to Eculizumab Due to Complement C5 Polymorphisms
Status: , Estimated PCD: 2024-06-01
Clinical trial
Coversin in Paroxysmal Nocturnal Haemoglobinuria (PNH) in Patients With Resistance to Eculizumab Due to Complement C5 Polymorphisms
Status: Completed, Estimated PCD: 2018-03-20